Genomic Advances in Drug Discovery & Development - Lon Cardon, Ph.D.
Dr. Cardon joined GlaxoSmithKline in 2008, initially as head of Genetics. He is now head of Alternative Discovery and Development, a pan-therapeutic division focused on nontraditional approaches for drug discovery and development.